UTMB News Articles

  • What pharmacy leaders are betting on for the next 3 years

    “Over the next two to three years, our organization is strategically focused on growth opportunities that reflect both the evolving needs of our patients and the rapid transformation of pharmacy practice,” UTMB’s Michael Eagon tells Becker’s for this article on growth opportunities.

  • Study questions antibiotic use for kids’ appendicitis

    Research by UTMB’s Dr. Isabella Faria and colleagues found that children with acute uncomplicated appendicitis (UA) treated with antibiotics alone faced significantly higher risks of treatment failure and serious complications within a year compared with those who underwent appendectomy. "What we're seeing now is that, as the volume and quality of evidence increase, a clearer signal is emerging: nonoperative management is associated with higher failure rates and more complications," Faria told MedPage Today.

  • Confused about the new covid shot? Here’s the bottom line

    “This updated recommendation means the Covid vaccine is available to everyone six months and older,” write Drs. Megan Berman and Richard Rupp in their latest Vaccine Smarts column. While recent changes to Covid vaccine guidelines have caused some confusion, Berman and Rupp write that the good news is the vaccine is available for everyone six months and older and patients are encouraged to have a conversation with their health care provider about the vaccine.

  • Houston Moms talks with Pediatric Urologist Dr. Jonathan Gerber

    UTMB Pediatric Urologist Dr. Jonathan Gerber spoke with Houston Moms host Meagan Clanahan, covering topics like circumcision, bedwetting, and other common urological issues in children. Get expert insights and practical advice every parent should hear.

  • Glenn Sanford, JD, PhD, University of Houston Clear Lake; Rashid Mosavin, RPH, PhD, MBA, Texas Southern University; Randy Urban, MD, UTMB; Ed Jones, MBA, Houston Methodist

    UTMB awarded prestigious $29 million NIH Clinical and Translational Science Award to lead Greater Gulf Coast Translational Science Alliance

    The University of Texas Medical Branch has been awarded a seven-year, $29 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) to establish and lead the new Greater Gulf Coast Translational Science Alliance (GGCTSA).

  • UTMB receives prestigious $29 million award to establish alliance

    UTMB is the recipient of a seven-year, $29 million Clinical and Translational Science Award from to establish and lead the new Greater Gulf Coast Translational Science Alliance. “This award allows us to bring together the unique strengths of four institutions to impact the Houston/Galveston biomedical ecosystem,” said Dr. Randall Urban.

  • Understanding over-the-counter meds

    Dr. Samuel Mathis takes some time in this week’s column to explore how over-the-counter pain relievers work. “Over-the-counter medications are generally safe when used appropriately according to their instructions,” Mathis writes.

  • Processed meats and the risk of colorectal cancer

    Recent studies have focused on the consumption of meat, especially processed meats, as an important risk factor for colorectal cancer, write Drs. Norbert Herzog and David Niesel in their latest Medical Discover News column. They write that according to a recent study, “Eating just 2.5 ounces a day of red and processed meats led to a 32 percent and 40 percent greater risk, respectively, for colorectal cancer.”

  • Cancer from CT scans: What’s the real risk?

    Medscape reports on a study published earlier this year that found that CT scans may be a major cause of cancer. Those results are disputed by many. Medscape quoted a letter penned by UTMB’s Chris Hsu, Alexander David and Dr. James Roberts that states the study doesn’t take recent innovations in medical imaging into account. “This leads to an overestimation of the projected risk of cancer alongside the upward trend of CT use,” Medscape quotes from the letter.

  • Dr. Yungeng Chen Assistant Professor in the Department of Biochemistry & Molecular Biology

    Nature Communications study on “clots under stress” earns UTMB's 2025 Horizon Award for Dr. Yunfeng Chen

    A groundbreaking University of Texas Medical Branch study that revealed how blood clots form under pressure has earned national recognition. The research, led by Yunfeng Chen, PhD, assistant professor in the Department of Biochemistry & Molecular Biology, has been awarded the 2025 Horizon Award, which includes a $15,000 prize honoring an outstanding publication of the past year.

  • CEOs on the ‘where’ and ‘how’ of redefining growth

    Dr. Jochen Reiser, president of UTMB and CEO of UTMB Health, spoke to Becker’s about rethinking what growth means and how organizations deliver care. “UTMB’s most unexpected growth has been in pharmacy, where retail and specialty services have delivered more than 30% compound annual growth rate over the past three years,” Reiser said.

  • UTMB testing nasal spray as new hope for Alzheimer’s treatment

    Dr. Vineet Gupta joined KHOU to talk about a nasal spray treatment for Alzheimer’s developed at UTMB. “You are looking at six to eight years before all the testing is complete and this becomes a medicine that doctors are able to prescribe,” Gupta said.

  • UTMB hosts symposium on psychiatry and women’s health

    The University of Texas Medical Branch welcomed three celebrated researchers as presenters at the “Navigating Dual Frontiers: Psychiatry & Women’s Health Symposium,” happening today in Levin Hall.

Categories